Genotype and phenotype correlations in Iranian patients with hyperinsulinaemic hypoglycaemia

BMC Research Notes

Khalid Hussain⁶  Mansour Salehi⁴  Majid Hosseinzadeh⁷  Mahin Hashemipour¹  Sian Ellard³  Sarah E Flanagan³  Atefeh Sadeghizadeh²  Senthil Senniappan⁵ 

[1] Endocrinology and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran;Department of Pediatrics, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran;Institute Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK;Pediatric Inherited Disease Research Center (PIDRC), Isfahan University of Medical Sciences, Isfahan, Iran;Alder Hey Children’s Hospital, Liverpool, UK;Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children, London, UK;Medical Genetics Laboratory, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

关键词: Diazoxide;    HADH (hydroxyacyl-CoA-dehydrogenase);    Hyperinsulinaemic hypoglycaemia;   

Others  :  1230886
DOI  :  10.1186/s13104-015-1319-1

 received in 2014-10-29, accepted in 2015-08-04,  发布年份 2015

【 摘 要 】

Background

Hyperinsulinaemic hypoglycaemia (HH) is a group of clinically and genetically heterogeneous disorders characterized by unregulated insulin secretion. Abnormalities in nine different genes (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, HNF4A, UCP2 and HNF1A) have been reported in HH, the most common being ABCC8 and KCNJ11. We describe the genetic aetiology and phenotype of Iranian patients with HH.

Methods

Retrospective clinical, biochemical and genetic information was collected on 23 patients with biochemically confirmed HH. Mutation analysis was carried out for the ATP-sensitive potassium (K _ATP ) channel genes (ABCC8 and KCNJ11), GLUD1, GCK, HADH and HNF4A.

Results

78 % of the patients were identified to have a genetic cause for HH. 48 % of patients had mutation in HADH, whilst ABCC8/KCNJ11 mutations were identified in 30 % of patients. Among the diazoxide-responsive patients (18/23), mutations were identified in 72 %. These include two novel homozygous ABCC8 mutations. Of the five patients with diazoxide-unresponsive HH, three had homozygous ABCC8 mutation, one had heterozygous ABCC8 mutation inherited from an unaffected father and one had homozygous KCNJ11 mutation. 52 % of children in our cohort were born to consanguineous parents. Patients with ABCC8/KCNJ11 mutations were noted to be significantly heavier than those with HADH mutation (p = 0.002). Our results revealed neurodevelopmental deficits in 30 % and epilepsy in 52 % of all patients.

Conclusions

To the best of our knowledge, this is the first study of its kind in Iran. We found disease-causing mutations in 78 % of HH patients. The predominance of HADH mutation might be due to a high incidence of consanguineous marriage in this population. Further research involving a larger cohort of HH patients is required in Iranian population.

【 授权许可】

   
2015 Senniappan et al.

【 图 表 】

Fig.1.

【 参考文献 】

• [1]Senniappan S, Shanti B, James C, Hussain K: Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Inherit Metab Dis 2012, 35:589-601.
• [2]Senniappan S, Arya VB, Hussain K: The molecular mechanisms, diagnosis and management of congenital hyperinsulinism. Indian J Endocrinol Metab 2013, 17:19-30.
• [3]Bruining GJ: Recent advances in Hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990, 2:758-765.
• [4]Mathew PM, Young JM, Abu-Osba YK, Mulhern BD, Hammoudi S, Hamdan JA, et al.: Persistent neonatal hyperinsulinism. Clin Pediatr (Phila) 1988, 27:148-151.
• [5]Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fekete C, De Lonlay-Debeney P, et al.: Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000, 82:F98-F107.
• [6]Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, et al.: Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007, 4:e118.
• [7]Rahier J, Guiot Y, Sempoux C: Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 2000, 82:F108-F112.
• [8]Stanescu DE, Hughes N, Kaplan B, Stanley CA, De León DD: Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 2012, 97(10):E2026-E2030.
• [9]Kane C, Shepherd RM, Squires PE, Johnson PR, James RF, Milla PJ, et al.: Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 1996, 2:1344-1347.
• [10]Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL: A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels. J Biol Chem 2006, 281:3006-3012.
• [11]Pinney SE, MacMullen C, Becker S, Lin YW, Hanna C, Thornton P, et al.: Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest 2008, 118:2877-2886.
• [12]Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr 2001, 138:383-389.
• [13]Kapoor RR, Locke J, Colclough K, Wales J, Conn JJ, Hattersley AT, et al.: Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 2008, 57:1659-1663.
• [14]Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, et al.: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest 2001, 108:457-465.
• [15]Martins E, Cardoso ML, Rodrigues E, Barbot C, Ramos A, Bennett MJ, et al.: Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: the clinical relevance of an early diagnosis and report of four new cases. J Inherit Metab Dis 2011, 34:835-842.
• [16]Kapoor RR, James C, Flanagan SE, Ellard S, Eaton S, Hussain K: 3-Hydroxyacyl-coenzyme A dehydrogenase deficiency and hyperinsulinemic hypoglycemia: characterization of a novel mutation and severe dietary protein sensitivity. J Clin Endocrinol Metab 2009, 94:2221-2225.
• [17]Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, et al.: Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem 2010, 285:31806-31818.
• [18]Flanagan SE, Patch AM, Locke JM, Akcay T, Simsek E, Alaei M, et al.: Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees. J Clin Endocrinol Metab 2011, 96:E498-E502.
• [19]Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S, Hussain K: Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013, 168:557-564.
• [20]Snider KE, Becker S, Boyajian L, Shyng SL, MacMullen C, Hughes N: Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013, 98:E355-E363.
• [21]Faletra F, Athanasakis E, Morgan A, Biarnés X, Fornasier F, Parini R, et al.: Congenital hyperinsulinism: clinical and molecular analysis of a large Italian cohort. Gene 2013, 521:160-165.
• [22]Saadat M, Ansari-Lari M, Farhud DD: Consanguineous marriage in Iran. Ann Hum Biol 2004, 31:263-269.
• [23]Park SE, Flanagan SE, Hussain K, Ellard S, Shin CH, Yang SW: Characterization of ABCC8 and KCNJ11 gene mutations and phenotypes in Korean patients with congenital hyperinsulinism. Eur J Endocrinol 2011, 164:919-926.
• [24]Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njølstad PR, et al.: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes 2004, 53:221-227.
• [25]Mercimek-Mahmutoglu S, Rami B, Feucht M, Herle M, Rittinger O, Stoeckler-Ipsiroglu S, et al.: Long-term follow-up of patients with congenital hyperinsulinism in Austria. J Pediatr Endocrinol Metab 2008, 21:523-532.
• [26]Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E: Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003, 149:43-51.
• [27]Cresto JC, Abdenur JP, Bergada I, Martino R: Long-term follow up of persistent hyperinsulinaemic hypoglycaemia of infancy. Arch Dis Child 1998, 79:440-444.
• [28]Dacou-Voutetakis C, Psychou F, Maniati-Christidis M: Persistent hyperinsulinemic hypoglycemia of infancy: long-term results. J Pediatr Endocrinol Metab 1998, 11(Suppl 1):131-141.
• [29]Duvanel CB, Fawer CL, Cotting J, Hohlfeld P, Matthieu JM: Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr 1999, 134:492-498.
• [30]Rovet JF, Ehrlich RM: The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr 1999, 134:503-506.
• [31]Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, et al.: Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism. Front Endocrinol (Lausanne) 2013, 4:60.